Symbotic director Kane proposes $270K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Symbotic Inc. director Charles Kane reported a proposed sale of 6,000 common shares, with an approximate sale date of July 1, 2026, and an aggregate market value of $269,700. The shares are listed as acquired from the issuer in a private acquisition on June 7, 2022. Kane’s reported prior transactions include 2,000 shares sold on May 1, 2026, for gross proceeds of $116,525.20, and 2,000 shares sold on June 1, 2026, for gross proceeds of $91,980; both are identified as 10b5-1 sales. The stated plan adoption date is December 8, 2025.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
Private Acquisition from Issuer or an Affiliate financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior SYM sales did Charles Kane report?
AI-generated analysis. How Rhea-AI works. Not financial advice.